MX7113E - Procedimiento para aislar composiciones que contienen fibronectina,a partir de un crioprecipitado de plasma sanguineo - Google Patents
Procedimiento para aislar composiciones que contienen fibronectina,a partir de un crioprecipitado de plasma sanguineoInfo
- Publication number
- MX7113E MX7113E MX819332U MX933281U MX7113E MX 7113 E MX7113 E MX 7113E MX 819332 U MX819332 U MX 819332U MX 933281 U MX933281 U MX 933281U MX 7113 E MX7113 E MX 7113E
- Authority
- MX
- Mexico
- Prior art keywords
- blood plasma
- compositions containing
- cryprecipitate
- procedure
- containing fibronectin
- Prior art date
Links
- 102000016359 Fibronectins Human genes 0.000 title abstract 3
- 108010067306 Fibronectins Proteins 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 210000002381 plasma Anatomy 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
- Y10S530/831—Cohn fractions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/127,340 US4341764A (en) | 1980-03-05 | 1980-03-05 | Method of preparing fibronectin and antihemophilic factor |
Publications (1)
Publication Number | Publication Date |
---|---|
MX7113E true MX7113E (es) | 1987-06-29 |
Family
ID=22429606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX819332U MX7113E (es) | 1980-03-05 | 1981-03-05 | Procedimiento para aislar composiciones que contienen fibronectina,a partir de un crioprecipitado de plasma sanguineo |
Country Status (9)
Country | Link |
---|---|
US (1) | US4341764A (es) |
EP (1) | EP0035202B1 (es) |
JP (1) | JPS56139418A (es) |
AT (1) | ATE15973T1 (es) |
CA (1) | CA1164342A (es) |
DE (1) | DE3172567D1 (es) |
DK (1) | DK156697C (es) |
ES (1) | ES500122A0 (es) |
MX (1) | MX7113E (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4440679A (en) * | 1980-03-05 | 1984-04-03 | Cutter Laboratories, Inc. | Pasteurized therapeutically active protein compositions |
JPS584074U (ja) * | 1981-06-30 | 1983-01-11 | 井上 岱介 | 風車ネオン式検電器 |
DE3170868D1 (en) * | 1981-10-12 | 1985-07-11 | Armour Pharma | Process for the preparation of highly purified antihemophilic factor |
US4391749A (en) * | 1981-10-19 | 1983-07-05 | La Jolla Cancer Research Foundation | Method for the purification of collagens |
JPS5967228A (ja) * | 1982-10-07 | 1984-04-16 | Green Cross Corp:The | 寒冷不溶性グロブリンの凍結乾燥方法 |
JPS59134732A (ja) * | 1983-01-21 | 1984-08-02 | Green Cross Corp:The | フイブロネクチン・生理活性物質複合体の製造法 |
DE3318521A1 (de) * | 1983-05-20 | 1984-11-22 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats |
JPS6133124A (ja) * | 1983-11-04 | 1986-02-17 | ラルフ シルヴア−マン | 異性々疾患を治療するための培養間葉細胞から抽出した巨大分子 |
US4965199A (en) * | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
AT385658B (de) * | 1985-03-28 | 1988-05-10 | Serotherapeutisches Inst Wien | Verfahren zur herstellung einer fuer die anwendung beim menschen geeigneten fibronektinloesung |
US4587122A (en) * | 1985-04-23 | 1986-05-06 | The Green Cross Corporation | Fibronectin-dextran-drug complex and method of preparation thereof |
US4894328A (en) * | 1986-03-26 | 1990-01-16 | Board Of Regents, The University Of Texas System | Immunodiagnostic test for syphilis and other treponemal infections |
DK475386D0 (da) | 1986-10-03 | 1986-10-03 | Weis Fogh Ulla Sivertsen | Fremgangsmaade og apparat til fremstilling af biologiske stoffer |
FR2632309B1 (fr) * | 1988-06-07 | 1990-08-24 | Lille Transfusion Sanguine | Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus |
US5453489A (en) * | 1992-01-31 | 1995-09-26 | La Jolla Cancer Research Foundation | Polypeptide fragments of fibronectin which can modulate extracellular matrix assembly |
US5629291A (en) * | 1992-01-31 | 1997-05-13 | La Jolla Cancer Research Foundation | Methods of modulating fibronectin extracellular matrix assembly |
US7112320B1 (en) * | 1995-06-07 | 2006-09-26 | Andre Beaulieu | Solid wound healing formulations containing fibronectin |
US5821220A (en) * | 1995-06-07 | 1998-10-13 | Andre Beaulieu | Method of producing concentrated non-buffered solutions of fibronectin |
US6528483B2 (en) * | 1995-06-07 | 2003-03-04 | André Beaulieu | Method of producing concentrated non-buffered solutions of fibronectin |
CA2318440A1 (en) | 1998-01-23 | 1999-07-29 | Csl Limited | Purification of fibrinogen |
EP1154796B1 (en) * | 1999-02-22 | 2007-06-20 | University of Connecticut | Novel albumin-free factor viii formulations |
EP1240200B1 (en) * | 1999-12-23 | 2009-06-03 | Csl Limited | Separation of fibrinogen from plasma proteases |
AU779126B2 (en) * | 1999-12-23 | 2005-01-06 | Csl Limited | Separation of fibrinogen from plasma proteases |
DE102004044429B4 (de) * | 2004-09-14 | 2009-04-30 | Biotest Ag | Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor |
DE102004044419B4 (de) | 2004-09-14 | 2010-04-15 | Biotest Ag | Verfahren zur Aufreinigung eines von Willebrand Faktors mittels Hydroxylapatit-Durchlaufchromatographie |
BRPI0921429B1 (pt) | 2008-11-07 | 2022-07-12 | Takeda Pharmaceutical Company Limited | Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável |
MX2011012502A (es) | 2009-05-25 | 2011-12-12 | Lundbeck & Co As H | Metodo para la preparacion de hidrocloruro de nalmefeno. |
IL213864A0 (en) | 2011-06-30 | 2011-08-31 | Omrix Biopharmaceuticals Ltd | Method for removing a lytic enzyme from a heterogeneous mixture |
US8844879B2 (en) * | 2011-12-12 | 2014-09-30 | The Boeing Company | Wing variable camber trailing edge tip |
IL231230A0 (en) | 2014-02-27 | 2014-08-31 | Omrix Biopharmaceuticals Ltd | Fibrinogen preparation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3973002A (en) * | 1974-04-12 | 1976-08-03 | E. R. Squibb & Sons, Inc. | Antihemophilic factor |
US4170639A (en) * | 1978-07-10 | 1979-10-09 | Warner-Lambert Company | Antihemophilic factor concentrate and its production |
DE2848529A1 (de) * | 1978-11-09 | 1980-05-29 | Behringwerke Ag | Verfahren zur herstellung des kaelteunloeslichen globulins und dieses enthaltende arzneimittel |
US4278594A (en) * | 1979-06-19 | 1981-07-14 | David Amrani | Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma |
US4210580A (en) * | 1979-06-19 | 1980-07-01 | David Amrani | Process for separation and isolation of AHF and fibronectin from blood plasma |
-
1980
- 1980-03-05 US US06/127,340 patent/US4341764A/en not_active Expired - Lifetime
-
1981
- 1981-02-23 DE DE8181101288T patent/DE3172567D1/de not_active Expired
- 1981-02-23 AT AT81101288T patent/ATE15973T1/de not_active IP Right Cessation
- 1981-02-23 EP EP81101288A patent/EP0035202B1/en not_active Expired
- 1981-03-04 CA CA000372253A patent/CA1164342A/en not_active Expired
- 1981-03-04 JP JP3000681A patent/JPS56139418A/ja active Pending
- 1981-03-04 DK DK098581A patent/DK156697C/da not_active IP Right Cessation
- 1981-03-05 MX MX819332U patent/MX7113E/es unknown
- 1981-03-05 ES ES500122A patent/ES500122A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
US4341764A (en) | 1982-07-27 |
ATE15973T1 (de) | 1985-10-15 |
JPS56139418A (en) | 1981-10-30 |
DE3172567D1 (en) | 1985-11-14 |
ES8202029A1 (es) | 1982-01-01 |
DK156697B (da) | 1989-09-25 |
DK98581A (da) | 1981-09-06 |
ES500122A0 (es) | 1982-01-01 |
EP0035202A2 (en) | 1981-09-09 |
EP0035202B1 (en) | 1985-10-09 |
EP0035202A3 (en) | 1982-09-01 |
CA1164342A (en) | 1984-03-27 |
DK156697C (da) | 1990-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX7113E (es) | Procedimiento para aislar composiciones que contienen fibronectina,a partir de un crioprecipitado de plasma sanguineo | |
NO160600C (no) | Fremgangsmaate for flytendegjoering av naturgass. | |
ES522310A0 (es) | Un metodo de tratar una composicion sustancialmente seca que incluye factor viii de plasma sanguineo. | |
ES2046996T3 (es) | Procedimiento para purificar organofosfitos terciarios. | |
NO901665L (no) | Fremgangsmaate ved utvinning av naturgass. | |
ES507559A0 (es) | Un metodo de aislar esteroles, particularmente colesterol, en cantidades comerciales, a partir de un material que los contiene. | |
NZ253294A (en) | Extraction of prothrombin from blood | |
FI971000A (fi) | Kantasolujen jakautumista hidastava aine ja sen käyttö | |
ATE38036T1 (de) | Benzothiophenderivate als bronchodilatoren. | |
ES8607207A1 (es) | Procedimiento para la obtencion de nuevos esteres de acido salicilico de efecto perfumante | |
DE3174509D1 (en) | Glutathione peroxidase, process for production thereof, method and composition for the quantitative determination of lipid peroxide | |
ES8302632A1 (es) | Un procedimiento para la preparacion de derivados de 9-carbamoil-9-aminoalquilfluoreno. | |
DK151273C (da) | Fremgangsmaade til fremstilling af cholesterolbiosynteseinhibitoren mb- 530a. | |
NO158549C (no) | Fremgangsmaate for avsverting av sverteholdige sekundaere fiberkilder. | |
SE8404334D0 (sv) | 16-fluoro-16,17-didehydro-prostanoids and process for their preparation | |
ES8404183A1 (es) | Un procedimiento para la preparacion de composiciones farmaceuticas orales de acido propionhidroxamico. | |
ES2126923T3 (es) | 8-fluoro-antraciclinas, procedimientos para su preparacion y composiciones farmaceuticas que las contienen. | |
NO863472D0 (no) | Fremgangsmaate for konvertering av naturgass. | |
JPS5581584A (en) | Culture for isolating serratia | |
MX158726A (es) | Un procedimiento para la preparacion de gases que contienen hidrogeno | |
JPS56154451A (en) | Isolation of 1-naphthylamine-4,6- and 1-naphthylamine-4,7-disulfonic acid | |
JPS5439070A (en) | Agents for improving perfume and tast of tabacco | |
ATE34386T1 (de) | 1,2,3,4-tetrahydro-1-aminomethyl-4-phenylisochinoline und verfahren zu ihrer herstellung. | |
SE8205568D0 (sv) | Diastereomers | |
SE8201285L (sv) | Forpackning for planterbara plantor |